US6204261B1
(en)
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
US5985863A
(en)
|
1996-09-12 |
1999-11-16 |
Vertex Pharmaceuticals, Inc. |
Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
|
US5874424A
(en)
|
1995-12-20 |
1999-02-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US6008217A
(en)
|
1995-12-20 |
1999-12-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
IN151496B
(zh)
|
1980-02-26 |
1983-05-07 |
Chamanlal Jagannath Shishoo |
|
FI95572C
(fi)
|
1987-06-22 |
1996-02-26 |
Eisai Co Ltd |
Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
|
JP2777159B2
(ja)
|
1988-12-22 |
1998-07-16 |
エーザイ株式会社 |
環状アミン誘導体を含有する医薬
|
US5124335A
(en)
|
1991-01-30 |
1992-06-23 |
Merck & Co., Inc. |
Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists
|
US5262564A
(en)
|
1992-10-30 |
1993-11-16 |
Octamer, Inc. |
Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
|
US6420522B1
(en)
|
1995-06-05 |
2002-07-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US5716929A
(en)
|
1994-06-17 |
1998-02-10 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1β converting enzyme
|
US5756466A
(en)
|
1994-06-17 |
1998-05-26 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1β converting enzyme
|
US5847135A
(en)
|
1994-06-17 |
1998-12-08 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US20120165319A1
(en)
|
1995-12-20 |
2012-06-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1 beta converting enzyme
|
FR2750862B1
(fr)
|
1996-07-12 |
1998-10-16 |
Dupin Jean Pierre |
Utilisation d'heterocycles diazotes fusionnes avec un systeme aromatique ou heteroaromatique pour le traitement des maladies thrombo-emboliques
|
DE69808282T2
(de)
|
1997-05-08 |
2003-05-15 |
Aventis Cropscience Uk Ltd |
Verwendung von Thienopyrimidinen als Fungizide
|
US6444816B1
(en)
|
1997-10-27 |
2002-09-03 |
Dr. Reddy's Research Foundation |
Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
|
AU1120599A
(en)
|
1998-04-23 |
1999-03-08 |
Dr. Reddy's Research Foundation |
New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
|
NL1011737C2
(nl)
|
1999-04-06 |
2000-10-09 |
Ct For Immunopharmacology |
Verbinding voor het remmen van de influx van polymorphonucleaire leukocyten (PMNs) in een weefsel, werkwijze voor het selecteren van een dergelijke verbinding, een farmaceutisch preparaat en een toepassing van de verbinding.
|
US6844367B1
(en)
|
1999-09-17 |
2005-01-18 |
Millennium Pharmaceuticals, Inc. |
Benzamides and related inhibitors of factor Xa
|
US6720317B1
(en)
|
1999-09-17 |
2004-04-13 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
US6632815B2
(en)
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
US20060183776A9
(en)
|
2000-03-03 |
2006-08-17 |
Eisai Co., Ltd. |
Liquid dosage formulations of donepezil
|
US20030153598A1
(en)
|
2000-07-25 |
2003-08-14 |
Raymond Pratt |
Methods for treating Parkinson's disease with cholinesterase inhibitors
|
PT1311272E
(pt)
|
2000-03-03 |
2007-02-28 |
Eisai R&D Man Co Ltd |
Novos métodos utilizando inibidores de colinesterase
|
WO2001094350A1
(en)
|
2000-06-07 |
2001-12-13 |
Almirall Prodesfarma S.A. |
6-phenylpyrrolopyrimidinedione derivatives
|
AU2001268712A1
(en)
|
2000-06-23 |
2002-01-08 |
Bristol-Myers Squibb Company |
1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor Xa inhibitors
|
JP2002105081A
(ja)
|
2000-07-28 |
2002-04-10 |
Nikken Chem Co Ltd |
新規チオフェンニ環化合物
|
PE20020394A1
(es)
|
2000-08-18 |
2002-06-21 |
Agouron Pharma |
Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
|
US20020169175A1
(en)
|
2001-02-05 |
2002-11-14 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutically acceptable salts of heterocyclic compounds
|
US6960595B2
(en)
|
2001-03-23 |
2005-11-01 |
Bristol-Myers Squibb Pharma Company |
5-6 to 5-7 Heterobicycles as factor Xa inhibitors
|
WO2003024456A1
(en)
|
2001-09-20 |
2003-03-27 |
Eisai Co., Ltd. |
Methods for treating and preventing migraines
|
WO2003032914A2
(en)
|
2001-10-17 |
2003-04-24 |
Eisai Co., Ltd. |
Methods for treating substance abuse with cholinesterase inhibitors
|
OA12790A
(en)
|
2002-03-13 |
2006-07-10 |
Janssen Pharmaceutica Nv |
New inhibitors of histone deacetylase.
|
WO2003092606A2
(en)
|
2002-05-01 |
2003-11-13 |
Eisai Co., Ltd. |
Cholinesterase inhibitors to prevent injuries caused by chemicals
|
US20070053976A1
(en)
|
2002-05-17 |
2007-03-08 |
Eisai R & D Management Co., Ltd. |
Novel combination of drugs as antidepressant
|
WO2004034963A2
(en)
|
2002-05-17 |
2004-04-29 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
WO2004014908A1
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
Heterobicylcic metalloproteinase inhibitors
|
AU2003253165A1
(en)
|
2002-08-13 |
2004-02-25 |
Warner-Lambert Company Llc |
Pyrimidine fused bicyclic metalloproteinase inhibitors
|
WO2004037176A2
(en)
|
2002-10-21 |
2004-05-06 |
Bristol-Myers Squibb Company |
Quinazolinones and derivatives thereof as factor xa inhibitors
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
DE602004007840T2
(de)
|
2003-03-18 |
2008-04-10 |
The Jordanian Pharmaceutical Manufacturing Co. Ltd. |
Pyrazolopyrimidinon und ihre Verwendung als PDE-Inhibitoren
|
DE602004022819D1
(de)
|
2003-06-06 |
2009-10-08 |
Vertex Pharma |
Von atp-bindende kassette transportern
|
US7286624B2
(en)
|
2003-07-03 |
2007-10-23 |
Navcom Technology Inc. |
Two-way RF ranging system and method for local positioning
|
EP1661897B1
(en)
|
2003-08-26 |
2013-12-04 |
Teijin Pharma Limited |
Pyrrolopyrimidinone derivative
|
US7557113B2
(en)
|
2003-08-26 |
2009-07-07 |
Teijin Pharma Limited |
Substituted pyrrolo[3,2-d]pyrimidine derivatives
|
WO2005035003A2
(en)
|
2003-09-22 |
2005-04-21 |
Dihedron Corporation |
Compositions and methods for increasing drug efficiency
|
US20050148534A1
(en)
|
2003-09-22 |
2005-07-07 |
Castellino Angelo J. |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
AU2004276337B2
(en)
|
2003-09-24 |
2009-11-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
EP1729761A4
(en)
|
2004-03-05 |
2008-09-03 |
Eisai Co Ltd |
TREATMENT OF CADASIL WITH CHOLINESTERASE INHIBITORS
|
US7253204B2
(en)
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
NZ551004A
(en)
|
2004-04-02 |
2010-07-30 |
Prana Biotechnology Ltd |
Neurologically-active compounds
|
US20080045500A1
(en)
|
2004-07-01 |
2008-02-21 |
Eisai R&D Management Co., Ltd. |
Nerve Regeneration Stimulator
|
US20060135507A1
(en)
|
2004-08-13 |
2006-06-22 |
Osamu Yokoyama |
Therapeutic agent for overactive bladder involved in aging
|
US20060172992A1
(en)
|
2004-08-13 |
2006-08-03 |
Eisai Co., Ltd. |
Therapeutic agent for overactive bladder resulting from cerebral infarction
|
CA2577275A1
(en)
|
2004-08-31 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
CA2584412C
(en)
|
2004-09-14 |
2017-05-09 |
Minerva Biotechnologies Corporation |
Methods for diagnosis and treatment of cancer
|
JP2006176503A
(ja)
|
2004-11-26 |
2006-07-06 |
Tohoku Univ |
脳血管障害を伴うアルツハイマー病治療薬
|
RU2382786C2
(ru)
|
2004-12-24 |
2010-02-27 |
ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. |
Бициклические производные пиррола
|
EP1876179B1
(en)
|
2005-04-28 |
2015-03-25 |
Takeda Pharmaceutical Company Limited |
Thienopyrimidone compounds
|
GB0510204D0
(en)
|
2005-05-19 |
2005-06-22 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
US7745447B2
(en)
|
2005-10-26 |
2010-06-29 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
|
AR056155A1
(es)
|
2005-10-26 |
2007-09-19 |
Bristol Myers Squibb Co |
Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica
|
RU2008129873A
(ru)
|
2005-12-23 |
2010-01-27 |
Новартис АГ (CH) |
Конденсированные гетероциклические соединения, полезные в качестве ингибиторов дпп-iv
|
WO2008024978A2
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Tetrahydroindolone and tetrahydroindazolone derivatives
|
TW200836743A
(en)
|
2007-01-29 |
2008-09-16 |
Xenon Pharmaceuticals Inc |
Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
|
EP2073799A4
(en)
|
2007-03-12 |
2009-08-19 |
Vm Discovery Inc |
NOVEL ACTIVE SUBSTANCES FROM CALCIUMIONAL CHANNEL MODULATORS
|
CN103087043A
(zh)
|
2007-03-16 |
2013-05-08 |
中国人民解放军军事医学科学院放射与辐射医学研究所 |
具有抗增殖活性的苯甲酰胺类衍生物及其药用制剂
|
US20100184706A1
(en)
|
2007-03-20 |
2010-07-22 |
Bachovchin William W |
Fap-activated chemotherapeutic compounds, and methods of use thereof
|
WO2008138126A1
(en)
|
2007-05-09 |
2008-11-20 |
Neuromed Pharmaceuticals Ltd. |
Bicyclic pyrimidine derivatives as calcium channel blockers
|
RU2345996C1
(ru)
|
2007-07-17 |
2009-02-10 |
Андрей Александрович Иващенко |
Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
|
RU2341527C1
(ru)
|
2007-07-17 |
2008-12-20 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Аннелированные азагетероциклы, включающие пиримидиновый фрагмент, способ их получения и ингибиторы pi3k киназ
|
US8648085B2
(en)
|
2007-11-30 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
EP2274308A1
(en)
|
2008-04-04 |
2011-01-19 |
Gilead Sciences, Inc. |
Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
|
CA2737219C
(en)
|
2008-08-11 |
2017-02-28 |
Tracy Keller |
Halofuginone analogs for inhibition of trna synthetases and uses thereof
|
US20110082158A1
(en)
|
2008-10-01 |
2011-04-07 |
Aleem Gangjee |
Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same
|
CA2772760A1
(en)
|
2008-12-23 |
2010-07-01 |
President And Fellows Of Harvard College |
Small molecule inhibitors of necroptosis
|
WO2010103547A2
(en)
|
2009-03-13 |
2010-09-16 |
Advinus Therapeutics Private Limited |
Substituted fused pyrimidine compounds
|
US8927718B2
(en)
|
2009-08-26 |
2015-01-06 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic ring derivative and use thereof
|
MX2012004289A
(es)
|
2009-10-13 |
2012-06-12 |
Msd Oss Bv |
Derivados de azina condensada para el tratamiento de enfermedades relacionadas con el receptor de acetilcolina.
|
KR101590764B1
(ko)
|
2009-11-13 |
2016-02-02 |
삼성전자주식회사 |
컴퓨팅 시스템 및 컴퓨팅 시스템의 메모리 관리 방법
|
US20130085133A1
(en)
|
2010-02-08 |
2013-04-04 |
Sourthern Research Institute Office of Commercialization and Intellectual Prop. |
Anti-viral treatment and assay to screenfor anti-viral agent
|
US8575114B2
(en)
|
2010-03-23 |
2013-11-05 |
Albany Molecular Research, Inc. |
SGLT-2 inhibitors, methods of making them, and uses thereof
|
WO2012054332A1
(en)
|
2010-10-18 |
2012-04-26 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
WO2012075393A2
(en)
|
2010-12-02 |
2012-06-07 |
President And Fellows Of Harvard College |
Activators of proteasomal degradation and uses thereof
|
WO2012096928A2
(en)
|
2011-01-10 |
2012-07-19 |
Glaxosmithkline Llc |
Pyrimidinone derivatives as fatty acid synthase inhibitors
|
GB201107768D0
(en)
|
2011-05-10 |
2011-06-22 |
Univ Manchester |
Riboswitches
|
EP2565186A1
(en)
|
2011-09-02 |
2013-03-06 |
Hybrigenics S.A. |
Selective and reversible inhibitors of ubiquitin specific protease 7
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
US9394297B2
(en)
|
2012-02-28 |
2016-07-19 |
Amgen Inc. |
Amides as pim inhibitors
|
GB201205164D0
(en)
|
2012-03-23 |
2012-05-09 |
Almac Discovery Ltd |
Pharmaceutical compounds
|
CA2896731A1
(en)
|
2012-12-28 |
2014-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibitors of the usp1/uaf1 deubiquitinase complex and uses thereof
|
KR101446680B1
(ko)
|
2013-02-08 |
2014-10-07 |
한국과학기술연구원 |
mGluR1 길항제로 작용하는 사이에노피리미디논 유도체
|
CN103833646A
(zh)
|
2014-02-28 |
2014-06-04 |
广东工业大学 |
一种脂肪氨基取代喹唑啉酮衍生物及其制备方法和应用
|
TWI698436B
(zh)
|
2014-12-30 |
2020-07-11 |
美商佛瑪治療公司 |
作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
|
MA41291A
(fr)
|
2014-12-30 |
2017-11-07 |
Forma Therapeutics Inc |
Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
|
WO2016126926A1
(en)
|
2015-02-05 |
2016-08-11 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US9932351B2
(en)
*
|
2015-02-05 |
2018-04-03 |
Forma Therapeutics, Inc. |
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
EP3253759A1
(en)
|
2015-02-05 |
2017-12-13 |
Forma Therapeutics, Inc. |
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
|